Imiquimod

CD4 antigen ; Mus musculus







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34364883 IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation. 2022 Jan 1
2 34931339 Decreased microRNA-126 expression in psoriatic CD4+ T cells promotes T-helper 17 cell differentiation and the formation of dermatitis in imiquimod-induced psoriasis-like mice. 2022 Apr 3
3 35173615 CB2R Deficiency Exacerbates Imiquimod-Induced Psoriasiform Dermatitis and Itch Through the Neuro-Immune Pathway. 2022 1
4 35562873 Free Fatty Acid Receptor 4 (FFA4) Activation Ameliorates Imiquimod-Induced Psoriasis in Mice. 2022 Apr 19 1
5 34537997 Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination. 2021 Nov 1
6 31678366 Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis. 2020 Jan 1
7 31773789 Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice. 2020 Feb 2
8 33007409 Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. 2020 Dec 1
9 33023784 Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3. 2020 Dec 2
10 30834454 Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes in Mice. 2019 May 1 1
11 31393597 Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice. 2019 Nov 1
12 31407330 Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. 2019 Dec 1
13 21389872 Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors. 2011 Apr 2